Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Bristol Myers Squibb logoBristol Myers Squibb BMY

The company said Mr. Gerald Storch notified its Board of Directors on March 13, 2024 that he will not stand for re-election to the Board at the 2024 Annual Meeting of Shareholders.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said Mr. Gerald Storch notified its Board of Directors on March 13, 2024 that he will not stand for re-election to the Board at the 2024 Annual Meeting of Shareholders.

  2. The company said the Board set the number of directors at ten, effective immediately after the 2024 Annual Meeting of Shareholders.

  3. The company said in the filing that the 2024 Annual Meeting of Shareholders is expected to be held on May 7, 2024.

  4. Bristol-Myers Squibb filed this Form 8-K under Item 5.02, which covers changes in directors and certain officers. The date of the earliest event reported is March 13, 2024, and the signing date is March 18, 2024.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Gerald Storch Won't Seek Re-Election to Board

The company said Mr. Gerald Storch notified its Board of Directors on March 13, 2024 that he will not stand for re-election to the Board at the 2024 Annual Meeting of Shareholders.

Source · Based on the filing body and exhibits

Board Sets Number of Directors

The company said the Board set the number of directors at ten, effective immediately after the 2024 Annual Meeting of Shareholders.

Source · Based on the filing body and exhibits

2024 Annual Meeting Expected Date

The company said in the filing that the 2024 Annual Meeting of Shareholders is expected to be held on May 7, 2024.

Source · Based on the filing body and exhibits

Form 8-K Item 5.02 Report on Officer and Director Changes

Bristol-Myers Squibb filed this Form 8-K under Item 5.02, which covers changes in directors and certain officers. The date of the earliest event reported is March 13, 2024, and the signing date is March 18, 2024.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.